This review is specifically designed to address the topic of CRRT based on the needs and interests of intensivists. Some of the materials, concepts, and formulas presented in this review have been drawn from a previous chapter authored by myself and intended for individuals whose primary interest is specifically dialysis[1]. Since this previous chapter was authored in 1994, similar material presented in this review has been updated in order to present the most current information.
Get full access to this article
View all access options for this article.
References
1.
Kaplan AA.Replacement of renal function by dialysis. 4th edJacobs CKjellstrand CMKoch KM, ed. Dordrecht: Kluwer Academic; 1996:390-417.
2.
Kramer P,Wigger W,Rieger J.Arteriovenous haemofiltration: a new and simple method for the treatment of over-hydrated patients resistant to diuretics.Klinische Wochen-schrift. 1977;55:1121-1122
3.
Kramer P,Seegers A,De Vivie R.Therapeutic potential of hemofiltration.Clin Nephrol. 1979;11:145-149
4.
Kramer P,Kaufhold G,Grone HJ.Management of anuric intensive-care patients with arterio-venous hemofiltration.Int J Artif Organs. 1980;3:225-230
5.
Colton CK,Henderson LW,Ford CA.Kinetics of hemodiafiltration: I. In vitro transport characteristics of a hollow fiber blood ultrafilter.J Lab Clin Med. 1975;85:355-371
6.
Henderson LW,Colton CK,Ford CA..Kinetics of hemodiafiltration: II. Clinical characterization of a new blood cleansing modality.J Lab Clin Med. 1975;85:372-391
7.
Nolph KD..Short dialysis, middle molecules and uremia.Ann Intern Med. 1977;86:93-97
8.
Kaplan AA,Longnecker RE,Folkert VW..Continuous arteriovenous hemofiltration: a report of six month's experience.Ann Intern Med. 1984;100:358-367
9.
Kaplan AA.Clinical protocol from the John Dempsey Hospital. Farmington, CT: University of Connecticut Health Center; 1985:
10.
Mault JR,Dirkes SM,Swartz RDContinuous hemofiltration: a reference guide for SCUF, CAVH and CAVHD. Ann Arbor, MI: University of Michigan Medical Center;
11.
Price CA.Standards of clinical practice for nephrology nursing. 3rd edBurrows-Hudson S, ed. Pitman, NJ: American Nephrology Nurses' Association; 1993:
12.
Paganini EP,Nakamoto S..Continuous slow ultrafiltration in oliguric acute renal failure.Trans Am Soc Artif Intern Organs. 1980;26:201-204
13.
Paganini EP.CAVH: proceedings of the international symposium on continuous arterio-venous hemofiltration. La Greca GFabris ARonco C, ed. Milan, Italy: Wichtig Editore; 1986:199-226.
14.
Paganini EP,Flaque J,Whitman G.Amino acid balance in patients with oliguric acute renal failure undergoing slow continuous ultrafiltration (SCUF).Trans Am Soc Artif Intern Organs. 1982;28:615-620
15.
Paganini EP,O'Hara P,Nakamoto S..Slow continuous ultrafiltration in hemodialysis resistant oliguric acute renal failure patients.Trans Am Soc Artif Intern Organs. 984:173-177
16.
Desio FJ,Paganini EP..Evaluation of slow continuous ultrafiltration in oliguric patients on intraaortic balloon pumps (abstract).Blood Purif. 1984;2:5
18.PaganiniEP.Slow continuous ultrafiltration (SCUF). Proceedings of the Third International Symposium on Acute Continuous Renal Replacement Therapy, Fort Lauderdale, Florida, March 1987:37–57
Domoto DT..Two years clinical experience with continuous arteriovenous hemofiltration in acute renal failure.Trans Am Soc Artif Intern Organs. 1985;31:581-585
Golper TA,Kaplan AA,Narasimhan N.Transmembrane pressures generated by filtrate line suction maneuvers and predilution fluid replacement during in vitro continuous arteriovenous hemofiltration.Int J Artif Organs. 1987;10:41-46
23.
Henderson LW..Pre vs. post dilution hemofiltration.Clin Nephrol. 1979;11:120-124
24.
Cheung AK,Alford MF,Wilson MW.Urea movement across erythrocyte membrane during artificial kidney treatment.Kidney Int. 1983;23:866-869
25.
Geronemus R,Von Albertini B,Glabman S.Enhanced small molecular clearances in hemofiltration.Proc Clin Dial Transplant Forum. 1978;8:147-151
26.
Kaplan AA..Predilution vs postdilution for continuous arteriovenous hemofiltration.Trans Am Soc Artif Intern Organs. 1985;31:28-32
27.
Kaplan AA..Clinical trials with predilution and vacuum suction: enhancing the efficiency of the CAVH treatment.Trans Am Soc Artif Intern Organs. 1986;32:49-51
28.
Kaplan AA.Enhanced efficiency during CAVH: clinical trials with predilution and suction. La Greca GFabris ARonco C, ed. Milan, Italy: Wichtig Editore; 1986:49-54.
Geronemus R,Schneider N..Continuous arteriovenous hemodialysis: a new modality for the treatment of acute renal failure.Trans Am Soc Artif Intern Organs. 1984;30:610-612
31.
Pallone TL,Hyver S,Petersen J..Blood-dialysate equilibrium during continuous arteriovenous hemodialysis.Trans Am Soc Artif Intern Organs. 1988;34:512-514
32.
Bonnardeaux A,Pichette V,Ouimet D.Solute clearances with high dialysate flow rates and glucose absorption from the dialysate in continuous arteriovenous hemodialysis.Am J Kidney Dis. 1992;19:31-38
33.
Sigler MM,Teehan BP,Van Valkenburgh D..Solute transport in continuous hemodialysis: a new treatment for acute renal failure.Kidney Int. 1987;32:562-571
34.
Yohay DA,Schwab SJ,Quarles LD..Parallel plates are more effective than hollow fiber dialyzers in continuous arteriovenous hemodialysis (abstract).J Am Soc Nephrol. 1990;1:382
Daugirdas JT,Bregman H,Rahman MA.Ultrafiltration control during continuous arteriovenous hemodialysis using paired volumetric dialysate pumps (letter).Int J Artif Organs. 1986;9:273
39.
Van Geelen JA,Vincent HH,Schalekamp MADH..Continuous arteriovenous haemofiltration and haemodiafillration in acute renal failure.Nephrol Dial Transplant. 1988;2:181-186
40.
Gibney RTN,Stollery DE,Lefebvre RE.Continuous arteriovenous hemodialysis: an alternative therapy for acute renal failure associated with critical illness.Can Med Assoc J. 1988;139:861-866
41.
Pattison ME,Lee SM,Ogden DA..Continuous arteriovenous hemodiafiltration: an aggressive approach to the management of acute renal failure.Am J Kidney Dis. 1988;11:43-47
42.
Domoto DT,Brown WW,Bruggensmith P..Removal of toxic levels of N-acetylprocainamide with continuous arteriovenous hemofiltration or continuous arteriovenous hemodiafiltration.Ann Intern Med. 1987;106:550-552
43.
Bellomo R,Kearly Y,Parkin G.Treatment of life threatening lithium toxicity with continuous arteriovenous hemodiafiltration.Crit Care Med. 1991;19:836-837
44.
Golper TA,Leone M..Backtransport of dialysate solutes during in vitro continuous arteriovenous hemodialysis.Blood Purif. 1989;7:223-229
45.
Morabito S,Gamberini M,Marzoli G.Efficiency of different hollow-fiber hemofilters in continuous arteriovenous hemodiafiltration (CAVHD) (abstract).J Am Soc Nephrol. 1993;4:370
46.
Canaud B,Beraud JJ,Mion C.CAVH: proceedings of the international symposium on continuous arteriovenous hemofiltration. La Greca GFabris ARonco C, ed. Milan, Italy: Wichtig Editore; 1986:185-189.
47.
Bouchet JL,Bourdenx JPh,Montoriol JCAVH: proceedings of the international symposium on continuous arterio-venous hemofiltration. La Greca GFabris ARonco C, ed. Milan, Italy: Wichtig Editore; 1986:319-324.
Morgan JM,Morgan C,Evans TW..Clinical experience of pumped arteriovenous haemofiltration in the management of patients in oliguric renal failure following cardiothoracic surgery.Int J Cardiol. 1988;21:259-267
50.
Wendon J,Smithies M,Sheppard M.Continuous high volume venous-venous haemofiltration in acute renal failure.Intensive Care Med. 1989;15:358-363
51.
Storck M,Hart! WH,Zimmerer E.Comparison of pump-driven and spontaneous haemofiltration in postoperative acute renal failure.Lancet. 1991;i:452-455
52.
Macias WL,Mueller BA,Scarim SK.Continuous veno-venous hemofiltration: an alternative to continuous arteriovenous hemofiltration and hemodiafiltration in acute renal failure.Am J Kidney Dis. 1991;18:451-458
53.
Golper TA,Price J..Continuous veno-venous hemofiltration for acute renal failure in the intensive care setting: technical considerations.Trans Am Soc Artif Intern Organs. 1994;40:936-939
54.
Kudoh Y,Iimura O..Slow continuous hemodialysis—new therapy for acute renal failure in critically ill patients—Part 1. Theoretical consideration and new technique.Jap Cir J. 1988;52:1171-1182
55.
Kudoh Y,Shiiki M,Sasa Y.Slow continuous hemodialysis—new therapy for acute renal failure in critically ill patients—Part 2. Animal experiments and clinical implication.Jap Cir J. 1988;52:1183-1190
56.
Tarn PYW,Huraib S,Mahan B.Slow continuous hemodialysis for the management of complicated acute renal failure.Clin Nephrol. 1988;30:79-35
57.
Bellomo R,Parkin G,Love J.A prospective comparative study of continuous arteriovenous hemodiafiltration and continuous venovenous hemodiafiltration in critically ill patients.Am J Kidney Dis. 1993;21:400-404
Mendelssohn DC,Wong JA,Feng P.Technical experience with the Prisma continuous venovenous renal replacement therapy system (abstract).Blood Purif. 1997;15:139
60.
Pallone TL,Hyver S,Petersen J..The simulation of continuous arteriovenous hemodialysis with a mathematical model.Kidney Int. 1989;35:125-133
Quinton W,Dillard D,Scribner BH..Cannulation of blood vessels for prolonged hemodialysis.Trans Am Soc Artif Intern Organs. 1960;6:104-109
64.
Zobel G,Trop M,Beitzke A.Vascular access for continuous arteriovenous hemofiltration in infants and young children.Artif Organs. 1988;12:16-19
65.
Jenkins RD,Kuhn RJ,Funk JE..Clinical implications of catheter variability on neonatal continuous arteriovenous hemofiltration.Trans Am Soc Artif Organs. 1988;34:108-111
66.
Uldall R..Vascular access for continuous renal replacement therapy.Semin Dial. 1996;9:93-97
67.
Spinowitz BS,Galler M,Golden RA.Subclavian vein stenosis as a complication of subclavian catheterization for hemodialysis.Arch Intern Med. 1987;147:305-307
68.
Lysaght MJ,Boggs DR,Ritger PCAVH: international symposium on continuous arterio-venous hemofiltration. La Greca GFabris ARonco C, ed. Milan, Italy: Wichtig Editore; 1986:77-85.
69.
Ronco C,Brendolan A,Bragantini L.Treatment of acute renal failure in newborns by continuous arterio-venous hemofiltration.Trans Am Soc Artif Organs. 1985;31:634-638
70.
Ronco C,Bosch JP,Lew SCAVH: international symposium on continuous arterio-venous hemofiltration. La Greca GFabris ARonco C, ed. Milan, Italy: Wichtig Editore; 1986:55-61.
Jenkins R,Chen B,Funk JE..Maximum ultrafiltration rate in continuous arteriovenous hemofiltration does not occur at the lowest level of the ultrafiltrate collection chamber.Am Soc Artif Intern Organs J. 1993;39:M618-M620
73.
Voerman HJ,Strack Van Schijndel RJM,Thijs LG..Continuous arterial-venous hemodiafiltration in critically ill patients.Crit Care Med. 1990;18:911-914
74.
Lauer A,Saccaggi A,Ronco C.Continuous arteriovenous hemofiltration in the critically ill patient.Ann Intern Med. 1983;99:455-460
75.
Lennander O,Mulec H.CAVH: international symposium on continuous arterio-venous hemofiltration. La Greca GFabris ARonco C, ed. Milan, Italy: Wichtig Editore; 1986:87-90.
76.
Ronco C,Brendolan A,Bragantini L.Technical and clinical evaluation of a new polyamide hollow fiber hemofilter for CAVH.Int J Artif Organs. 1988;11:33-38
77.
Kaplan AA,Golper TA..Sieving characteristics of a new polysulfone hemofilter for use with continuous arteriovenous hemofiltration.Int J Artif Organs. 1987;10:357-360
78.
Arakawa M,Nagao M,Gejyo F.Development of a new antithrombogenic continuous ultrafiltration system.Artif Organs. 1991;15:171-179
79.
Sigler Mil,Manns M..Membranes and devices used in continuous renal replacement therapy.Semin Dial. 1996;9:98-106
80.
Kramer P,Bohler J,Kehr A.Intensive care potential of continuous arteriovenous hemofiltration.Trans Am Soc Artif Organs. 1982;28:28-32
81.
Kaplan AA,Toueg S,Kennedy TL..Complement kinetics during continuous arteriovenous hemofiltration: studies with a new polysulfone hemofilter.Blood Purif. 1988;6:27-36
82.
Parnes EL,Shapiro WB..Anaphylactoid reactions in hemodialysis patients treated with AN69 dialyzers.Kidney Int. 1991;40:1148
83.
Schaefer RM,Fink E,Schaefer L.Role of bradykinin in anaphylactoid reactions during hemodialysis with AN69 dialyzers.Am J Nephrol. 1993;13:473
Jenkins RD,Jackson E,Kuhn R.Benefit of bicarbonate dialysis during CAVHD.Trans Am Soc Artif Intern Organs. 1990;36:M465-M466
86.
Olbricht C,Mueller C,Schurek HJ..Treatment of acute renal failure in patients with multiple organ failure by continuous spontaneous hemofiltration.Trans Am Soc Artif Intern Organs. 1982;28:33-37
87.
Kohen JA,Whitley KY,Kjellstrand CM..Continuous arteriovenous hemofiltration: a comparison with hemodialysis in acute renal failure.Trans Am Soc Artif Intern Organs. 1985;31:169-173
89.SpinowitzB.Anticoagulation in continuous arteriovenous hemofiltration. Proceedings of the Third International Symposium on Acute Continuous Renal Replacement Therapy, Fort Lauderdale, Florida, March 1987:106–110
Hampers CL,Blaufox MD,Merill JP..Anticoagulation rebound after hemodialysis.N Eng J Med. 1966;275:776-778
98.
Milne B,Rodgers K,Cervenko F.Hemodynamic effects of intra-aortic administration versus intravenous administration of protamine for reversal of heparin in man.Can Anaesth Soc J. 1983;30:347-351
99.
Kaplan AA,Petrillo R..Regional heparinization for continuous arterio-venous hemofiltration (CAVH).Trans Am Soc Artif Intern Organs. 1987;33:312-315
100.
Hory B,Cachoux A,Toulemonde F..Continuous arteriovenous hemofiltration with low-molecular weight heparin (letter).Nephron. 1985;41:125
101.
Mehta RL,Mcdonald BR,Aguilar MM.Regional citrate anticoagulation for continuous arterio-venous hemodialysis in critically ill patients.Kidney Int. 1990;38:976-981
102.
Zusman RM,Rubin RH,Cato AE.Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent.N Eng J Med. 1981;304:934-939
103.
Smith MC,Danviriyasup K,Crow JW.Prostacyclin substitution for heparin in long-term hemodialysis.Am J Med. 1982;73:669-678
104.
Zobel G,Trop M,Muntean W.Anticoagulation for continuous arteriovenous hemofiltration in children.Blood Purif. 1988;6:90-95
105.
Weeden J,Smithies M,Sheppard M.Continuous high volume venous-venous haemofiltration in acute renal failure.Int Care Med. 1989;15:358-363
106.
Pataca MI,Ramesh BR,Parmer A.Continuous arteriovenous haemodialysis in severe combined renal and respiratory failure.Blood Purif. 1992;10:262-268
Smith D,Paganini EP,Suhoza KProgress in artificial organs. Nose YKjellstrand CIvanovich P, ed. Cleveland: ISAO Press; 1986:226-230.
112.
Martin PY,Chevrolet JC,Suter P.Anticoagulation in patients treated by continuous venovenous hemofiltration: a retrospective study.Am J Kidney Dis. 1994;24:806-812
113.
Arakawa M,Suzuki Y,Nagao M.Development of a new antithrombogenic continuous ultrafiltration system (ACUS) and its clinical evaluation.Nephrol Dial Transplant. 1991;2 (suppl): 49-54
114.
Sieffert E,Mateo J,Deligeon N.Continuous arteriovenous hemofiltration using heparin-coated and non-heparin-coated membranes in critically ill patients: effects on platelet counts (abstract).Blood Purif. 1997;15:141
115.
Teschan PE,Baxter CR,O'Brien TF.Prophylactic hemodialysis in the treatment of acute renal failure.Am J Med. 1960;53:992-1016
116.
Kleinknecht D,Jungers P,Chanard J.Uremic and non-uremic complications in acute renal failure.Kidney Int. 1972;1:190-196
117.
Conger JD..A controlled evaluation of prophylactic dialysis in post-traumatic acute renal failure.J Trauma. 1975;15:1056-1063
118.
Gillium DM,Dixon BS,Yanover MJ.The role of intensive dialysis in acute renal failure.Clin Nephrol. 1986;25:249-255
119.
Kaplan AA..Extracorporeal blood purification in the treatment of acute renal failure with multiorgan involvement.Blood Purif. 1996;14:86-93
120.
Maroni BJ,Steinman TI,Mitch WE..A method for estimating nitrogen intake of patients with chronic renal failure.Kidney Int. 1985;27:58-65
121.
Sigler MH,Samuel S,Teehan BP..Amino acid removal during continuous arterio-venous hemodialysis (CAVHD) in acute renal failure patients receiving total parenteral nutrition (abstract).Blood Purif. 1988;6:357
Bellomo R,Mansfield D,Rumble S.Conventional dialysis versus acute continuous hemodiafiltration.Am Soc Artif Intern Organs J. 1992;38:M654-M657
124.
Clark WR,Murphy MH,Alaka KJ.Urea kinetics during continuous hemofiltration.Am Soc Artif Intern Organs J. 1992;38:M664-M667
125.
Clark WR,Mueller BA,Alaka KJ.A comparison of metabolic control by continuous and intermittent therapies in acute renal failure.J Am Soc Nephrol. 1994;4:1413-1420
126.
Kramer P,Bohler J,Kehr A.Intensive care potential of continuous arteriovenous hemofiltration.Trans Am Soc Artif Intern Organs. 1982;28:28-32
127.
Chima SC,Meyer L,Hummell C.Protein catabolic rate in patients with acute renal failure on continuous arteriovenous hemofiltration and total parenteral nutrition.J Am Soc Nephrol. 1993;3:1516-1521
128.
Davenport A,Roberts NB..Amino acid losses during continuous high-flux hemofiltration in the critically ill patient.Crit Care Med. 1989;17:1010-1013
129.
Davies SP,Reaveley DA,Brown EA.Amino acid clearances and daily losses in patients with acute renal failure treated by continuous arteriovenous hemodialysis.Crit Care Med. 1991;19:1510-1515
130.
Mokrzycki MH,Kaplan AA..Protein losses during continuous renal replacement therapy.J Am Soc Nephrol. 1996;7:2259-2263
131.
Golper TA,Wedel SK,Kaplan AA.Drug removal during continuous arteriovenous hemofiltration: theory and clinical observations.Int J Artif Organs. 1985;8:307-312
132.
Golper TA,Pulliam J,Bennett WM..Removal of therapeutic drugs by continuous arteriovenous hemofiltration.Arch Intern Med. 1985;145:1651-1652
133.
Kronfol NO,Lau AH,Colon-Rivera J.Effect of CAVH membrane types on drug-sieving coefficients and clearances.Trans Am Soc Artif Intern Organs. 1986;2:85-87
134.
134.ReyadSBarajasMSwartzRD, et al. Drug removal during continous arteriovenous hemofiltration. Contemp Dial Nephrol1989;May:30–12
135.
Lau AH,Pyle K,Kronfol NO.Removal of cephalosporins by continuous arteriovenous ultrafiltration (CAVU) and hemofiltration (CAVH).Int J Artif Organs. 1989;12:379-383
136.
Bellomo R,Mcgrath B,Boyce N..In vivo catecholamine extraction during continuous hemodiafiltration in inotropedependent patients.Trans Am Soc Artif Intern Organs. 1991;37:M324-M325
137.
Mueller BA,Scarim SK,Marias WL..Comparison of imipenem pharmacokinetics in patients with acute or chronic renal failure treated with continuous hemofiltration.Am J Kidney Dis. 1993;21:172-179
138.
Bennet WM,Aronoff GR,Golper TADrug rescribing in renal failure. 2nd edPhiladelphia: American College of Physicians; 1991:
139.
Kroh UF,Holl TJ,Steinhdausser W..Management of drug dosing in continuous renal replacement therapy.Semin Dial. 1996;9:161-165
Golper TA,Marx M,Shuler CReplacement of renal function by dialysis. 4th edJacobs CKjellstrand CMKoch KM, ed. Dordrecht: Kluwer Academic; 1996:750-820.
142.
Reynolds HN..Complications related to the use of continuous arterio-venous hemofiltration with dialysis (abstract).Crit Care Med. 1990;18:S192
143.
Kramer P.Arteriovenous hemofiltration: a kidney replacement therapy for the intensive care unit. Kramer P, ed. Berlin-Heidelberg: Springer-Verlag; 1985:206-212.
144.
Ronco C,Brendolan A,Bragantini L.Treatment of acute renal failure in the newborn by continuous arteriovenous hemofiltration.Kidney Int. 1986;29:908-915
145.
Ronco C,Brendolan A,Bragantini SCAVH: proceedings of the international symposium on continuous arterio-venous hemofiltration. La Greca GFabris ARonco C, ed. Milan, Italy: Wichtig Editore; 1986:263-276.
146.
Zobel G,Trop M,Ring ECAVH: proceedings of the international symposium on continuous arterio-venous hemofiltration. La Greca GFabris ARonco C, ed. Milan, Italy: Wichtig Editore; 1986:155-161.
147.
Leone MR,Jenkins RD,Golper TA.Early experience with continuous arteriovenous hemofiltration in critically ill pediatric patients.Crit Care Med. 1986;14:1058-1063
148.
Jenkins R..Special issues with continuous renal replacement therapy in pediatric patients.Semin Dial. 1996;9:179-183
Coraim FJ,Coraim HP,Ebermann R.Acute respiratory failure after cardiac surgery: clinical experience with the application of continuous arteriovenous hemofiltration.Crit Care Med. 1986;14:714-718
152.
Bellomo R,Tippiong P,Boyce N..Tumor necrosis factor clearances during veno-venous hemodiafiltration in the critically ill.Am Soc Artif Intern Organs. 1991;37:M322-M323
153.
Cottrell AC,Mehta RL..Cytokine kinetics in septic ARF patients on continuous veno-veno hemodialysis (abstract).J Am Soc Nephrol. 1992;3:279
154.
Gomez A,Wang R,Unruh H.Hemofiltration reverses left ventricular dysfunction during sepsis in dogs.Anesthesiology. 1990;73:671-685
155.
Stein B,Pfenninger E,Grunert A.The consequences of continuous hemofiltration on lung mechanics and extra-vascular lung water in a porcine endotoxic shock model.Intensive Care Med. 1991;17:293-298
156.
Grootendorst AF,Van Bommel EFH..The role of hemofiltration in the critically-ill intensive care unit patient: present and future.Blood Purif. 1993;11:209-223
157.
Journois D,Silvester W..Continuous hemofiltration in patients with sepsis or multiorgan failure.Semin Dial. 1996;9:173-178
158.
Grootendorst AF,Van Bommel EFH,Van Der Hoven B.High volume hemofiltration improves hemodynamics of endotoxin-induced shock in the pig.J Crit Care. 1992;7:67-72
159.
Grootendorst AF,Van Bommel EFH,Van Der Hoven B.High volume hemofiltration improves right ventricular function of endotoxin-induced shock in the pig.Intensive Care Med. 1992;18:235-240
160.
Van Bommel EFH,Grootendorst AF,Van Leengoed LAMG..Influence of high-volume hemofiltration on hemodynamics in porcine endotoxic shock (abstract).Blood Purif. 1992;10:88
161.
Grootendorst AF,Van Saase JL..The role of continuous renal replacement therapy in sepsis and multiorgan failure.Am J Kidney Dis. 1996;128 (suppl 3): S50-S57
162.
Schetz M,Ferdinande P,Van Den Berghe G.Removal of pro-inflammatory cytokines with renal replacement therapy: sense or non-sense?.Intensive Care Medicine. 1995;21:169-176
163.
Misler S,Nidus BD..Long-term ultrafiltration as a treatment of refractory congestive heart failure.NY State J Med. 1984;84:518-520
164.
Inoue T,Morooka S,Hayashi T.Effectiveness of continuous arterio-venous hemofiltration (CAVH) for patients with refractory heart failure (abstract).Jpn Circul J. 1988;52:772
165.
Kaplan AA.CAVH: proceedings of the international symposium on continuous arterio-venous hemofiltration. La Greca GFabris ARonco C, ed. Milan, Italy: Wichtig Editore; 1986:87-90.
166.
Bergerone S,Tognarelli G,Pacitti ACAVH: proceedings of the international symposium on continuous arterio-venous hemofiltration. La Greca GFabris ARonco C, ed. Milan, Italy: Wichtig Editore; 1986:247-253.
167.
Dileo M,Pacitti A,Bergerone S.Ultrafiltration in the treatment of refractory congestive heart failure.Clin Cardiol. 1988;11:449-452
Biasoli S,Barbaresi F,Barbiero M.Intermittent veno-venous hemofiltration as a chronic treatment for refractory and intractable heart failure.Am Soc Artif Intern Organs J. 1992;38:M658-M663
170.
Davenport A,Will EJ,Losowsky MS.Continuous arteriovenous haemofiltration in patients with hepatic encephalopathy and renal failure.Lancet. 1987;ii:295
171.
Davenport A,Will EJ,Davison AM.Changes in intra cranial pressure during haemofiltration in oliguric patients with grade IV hepatic encephalopathy.Nephron. 1989;53:142-146
172.
Davenport A..The management of established renal failure in patients with liver failure.Semin Dial. 1996;9:166-172
173.
Matsubara S,Kenji O,Kiyoaki O.Continuous removal of middle molecules by hemofiltration in patients with acute liver failure.Crit Care Med. 1990;18:1331-1338
174.
Bellomo R,Harris C,Kang Y.Combined veno-venous bypass and high volume hemofiltration during onhotopic liver transplantation.Am Soc Artif Intern Organs. 1993;39:954-956
Benjamin E,Geffroy V,Oropello J.Continuous veno-venous hemofiltration in patients with hepatic failure and orthotopic liver transplantation (abstract).Blood Purif. 1995;13:401
177.
Hammer G,Conley S,So S.CWH-D in combination with total hepatectomy and portocaval shunting-bridge to liver transplantation (abstract).Blood Purif. 1995;13:400-401
178.
Golper TA,Bennett WM..Drug removal by continuous arteriovenous hemofiltation—a review of the evidence in poisoned patients.Med Toxicol Adverse Drug Exp. 1988;3:341-349
179.
Raimondi F,Bianchi T,Emmi VCAVH: proceedings of the international symposium on continuous arterio-venous hemofiltration. La Greca GFabris ARonco C, ed. Milan, Italy: Wichtig Editore; 1986:135-137.
180.
Kohn OF,Kaplan AA..High bicarbonate solutions in the treatment of lactic acidosis with continuous renal replacement therapy (CWH and CWHD) (abstract).J Am Soc Nephrol. 1995;6:495
181.
Kirschbaum B,Galishoff M,Reines HD..Lactic acidosis treated with continuous hemodiafiltration and regional citrate anticoagalation.Crit Care Med. 1992;20:349-353
182.
Schou H,Knudsen F..Continuous arteriovenous hemofiltration—a new treatment in hypercalcemic crisis.Blood Purif. 1988;6:227-229
183.
Kramer P,Biege G.Arteriovenous hemofiltration: kidney replacement therapy for the intensive care unit. Kramer P, ed. Berlin: Springer-Verlag; 1985:196-199.
184.
Kruczynski K,Irvine-Bird K,Toffelmire EB.A comparison of continuous arteriovenous hemofiltration and intermittent hemodialysis in acute renal failure patients in the intensive care unit.Am Soc Artif Intern Organs J. 1993;39:M778-M781
185.
Mehta R,Mcdonald B,Gabbai F.Continuous versus intermittent dialysis for acute renal failure in the ICU. Results of a randomized multicenter trial (abstract).J Am Soc Nephrol. 1996;7:1457
Cerra FB,Negro F,Abrams J..Apache II score does not predict multiple organ failure or mortality in postoperative surgical patients.Arch Surg. 1990;125:519-522
188.
Le Gall JR,Lemeshow S..Do we need a new severity score?.Crit Care Med. 1991;19:857-858
